HDA taps Drew, Mauch to lead board of directors
The Healthcare Distribution Alliance, which represents primary pharmaceutical distributors, has elected Greg Drew, president of Value Drug, as chairman of HDA’s board of directors, and Bob Mauch, executive vice president and group president at AmerisourceBergen, as vice chairman.
Drew, who recently served as vice chairman, assumes the chairmanship from Cardinal Health Medical Segment CEO Jon Giacomin, who is leaving the board following two years as chairman.
“As the board of directors continues the critical work of promoting the savings, efficiencies and safety that distributors provide to the healthcare industry, it is my pleasure to welcome Greg and Bob into their new roles, while thanking Jon for his service to HDA,” HDA president and CEO John Gray said in a statement.
HDA also announced the appointment of Chad Gielen, president/CEO of Louisiana Wholesale Drug, to its executive committee.
The following were named to HDA's board of directors: Michael Broome, CEO of Mutual Wholesale Drug; Saul Factor, president of Smith Drug; Juan Carlos Hernandez, executive vice president and general manager of Drogueria Betances; Nishit Mehta, CEO of HyGen Pharmaceuticals; and Jacob Paskes, member, CEO of BluPax Pharmaceuticals.
Drew, who recently served as vice chairman, assumes the chairmanship from Cardinal Health Medical Segment CEO Jon Giacomin, who is leaving the board following two years as chairman.
“As the board of directors continues the critical work of promoting the savings, efficiencies and safety that distributors provide to the healthcare industry, it is my pleasure to welcome Greg and Bob into their new roles, while thanking Jon for his service to HDA,” HDA president and CEO John Gray said in a statement.
HDA also announced the appointment of Chad Gielen, president/CEO of Louisiana Wholesale Drug, to its executive committee.
The following were named to HDA's board of directors: Michael Broome, CEO of Mutual Wholesale Drug; Saul Factor, president of Smith Drug; Juan Carlos Hernandez, executive vice president and general manager of Drogueria Betances; Nishit Mehta, CEO of HyGen Pharmaceuticals; and Jacob Paskes, member, CEO of BluPax Pharmaceuticals.